Several readers may be interested in reviewing the editorial comment in the Houston Chronicle today, entitled “ How we should manage prostate cancer patients .” It was contributed by Dr. Christopher Logothetis, who is chairman of the Department of Genitourinary Medical Oncology at The University of Texas M.D. Anderson Cancer Center. Dr. Logothetis is a well-known and highly experienced specialist on research into and treatment of advanced prostate cancer.
Several readers may be interested in reviewing the editorial comment in the Houston Chronicle today, entitled “ How we should manage prostate cancer patients .” It was contributed by Dr. Christopher Logothetis, who is chairman of the Department of Genitourinary Medical Oncology at The University of Texas M.D. Anderson Cancer Center. Dr. Logothetis is a well-known and highly experienced specialist on research into and treatment of advanced prostate cancer.